Tracking down the origin of leukemia relapse

April 4, 2011, Rockefeller University

The cancer cells that reign during relapses of an aggressive human leukemia are different from those that dominated the original disease, according to a paper published online on April 4 in the Journal of Experimental Medicine.

By comparing the DNA of cancer cells taken at the time of diagnosis and relapse from patients with T cell acute lymphoblastic (T-ALL), Jean Soulier and co-workers found that the relapse cells arose from cells that were scarce at the time of diagnosis. The relapse cells had also picked up several new and dangerous mutations. Mimicking these mutations in cells isolated at diagnosis rendered them more cancerous after injection into immune-depleted mice.

Untouched cancer cells from diagnosis samples also caused leukemia when injected into mice. And once established, they bore a closer genetic resemblance to relapse cells than to their former selves, suggesting that the most aggressive prevail in both mouse and man.

These findings suggest that tracking human leukemia development in immune-depleted mice might provide insight into the mechanisms underlying relapses of the human disease.

More information: Clappier, E., et al. 2011. J. Exp. Med. doi:10.1084/jem.20110105

Related Stories

Recommended for you

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.